Research graph
References from A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer
10.1200/jco.2005.12.187 · 2005 · External reference
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
10.1056/nejmoa041318 · 2004 · External reference
Metronomic chemotherapy: principles and lessons learned from applications in the treatment of metastatic prostate cancer
10.1007/978-3-540-78281-0_10 · 2010 · External reference
The anti-angiogenic basis of metronomic chemotherapy
10.1038/nrc1369 · 2004 · External reference
Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide
10.1593/neo.101174 · 2011 · External reference
In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy
10.1016/j.jprot.2010.02.019 · 2010 · External reference
R: a language for data analysis and graphics
10.1080/10618600.1996.10474713 · 1996 · External reference
Summaries of Affymetrix GeneChip probe level data
10.1093/nar/gng015 · 2003 · External reference
Bioconductor: open software development for computational biology and bioinformatics
10.1186/gb-2004-5-10-r80 · 2004 · External reference
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
10.1038/nprot.2008.211 · 2008 · External reference
Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR
10.1007/s10529-006-9127-2 · 2006 · External reference
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice
10.1158/1535-7163.mct-07-0181 · 2007 · External reference
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
10.1186/1476-4598-9-55 · 2010 · External reference
Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation
10.1111/j.1365-2605.2009.01030.x · 2010 · External reference
Flavone acetic acid induces a coagulopathy in mice
10.1038/bjc.1989.348 · 1989 · External reference
The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains
10.1073/pnas.81.17.5355 · 1984 · External reference
Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family
10.1021/bi00417a011 · 1988 · External reference
Regulation of coagulation by protein S
10.1097/moh.0b013e328309ec97 · 2008 · External reference
Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis
10.1158/1535-7163.mct-11-0659 · 2012 · External reference
Tissue factor pathway
10.1053/beha.1999.0030 · 1999 · External reference
Initiation in vivo of blood coagulation. The role of white blood cells and tissue factor (author's transl)
1979 · External reference
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein
10.1038/nm841 · 2003 · External reference
Reorganizing the protein space at the Universal Protein Resource (UniProt)
10.1093/nar/gkr981 · 2012 · External reference
